Ekso Bionics Holdings Q1 2024 GAAP EPS $(0.20) Misses $(0.16) Estimate, Sales $3.756M Miss $4.993M Estimate

Ekso Bionics Holdings, Inc. +4.85%

Ekso Bionics Holdings, Inc.

EKSO

1.08

+4.85%

Ekso Bionics Holdings (NASDAQ: EKSO) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $3.756 million which missed the analyst consensus estimate of $4.993 million by 24.77 percent. This is a 8.88 percent decrease over sales of $4.122 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via